fenoxycarb has been researched along with Cushing's Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badiu, C; Brue, T; Cohen, F; Elenkova, A; Fleseriu, M; Georgescu, CE; Pivonello, R; Shimon, I; Stigliano, A; Tóth, M; Tsagarakis, S; Zacharieva, S | 1 |
| Gebarski, SS; Giordani, B; Schteingart, DE; Starkman, MN | 1 |
1 trial(s) available for fenoxycarb and Cushing's Syndrome
| Article | Year |
|---|---|
Levoketoconazole in the treatment of patients with endogenous Cushing's syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS).
Topics: Adrenal Insufficiency; Cushing Syndrome; Humans; Hydrocortisone; Logic; Treatment Outcome | 2022 |
1 other study(ies) available for fenoxycarb and Cushing's Syndrome
| Article | Year |
|---|---|
Improvement in learning associated with increase in hippocampal formation volume.
Topics: Adenoma; Adult; Caudate Nucleus; Cushing Syndrome; Endoscopy; Female; Follow-Up Studies; Hippocampus; Humans; Hydrocortisone; Hypophysectomy; Logic; Magnetic Resonance Imaging; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Paired-Associate Learning; Pituitary Neoplasms; Postoperative Complications; Problem Solving; Verbal Learning | 2003 |